Siemens Healthineers AG (MEX:SHL N) Research & Development: MXN41,639 Mil (TTM As of Mar. 2026)


MEX:SHL N Siemens Healthineers AG MEX:SHL N
72 GF Score
Price MXN918.93
GF Value MXN1,405.64
! 5 Warning Signs
View Full Analysis

What is Siemens Healthineers AG Research & Development?

Siemens Healthineers AG MEX:SHL N 72 Research & Development is MXN41,639 Mil as of Mar. 2026. GuruFocus rates MEX:SHL N with a GF Score™ of 72/100 and a GF Value™ of MXN1,405.64. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Siemens Healthineers AG's Research & Development for the three months ended in Mar. 2026 was MXN10,153 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was MXN41,639 Mil.

Siemens Healthineers AG  (MEX:SHL N) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Siemens Healthineers AG Research & Development Related Terms

Siemens Healthineers AG Research & Development Historical Data

* Premium members only.

The historical data trend for Siemens Healthineers AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Siemens Healthineers AG Research & Development Chart

Siemens Healthineers AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37,398.65 35,549.78 34,689.07 41,915.64 42,157.21

Siemens Healthineers AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,726.73 10,706.80 10,743.85 10,035.96 10,152.51
MEX:SHL N
72GF Score
Siemens Healthineers AG MEX:SHL N
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Siemens Healthineers AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN41,639 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MXN41,639 Mil mean?
Siemens Healthineers AG (MEX:SHL N) has a Research & Development of MXN41,639 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Siemens Healthineers AG and its competitors.
Is Siemens Healthineers AG's Research & Development too high?
Siemens Healthineers AG's current Research & Development is MXN41,639 Mil. Overall, Siemens Healthineers AG has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's Research & Development compare to ABT and SYK?
Siemens Healthineers AG's Research & Development of MXN41,639 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Siemens Healthineers AG and its competitors. Siemens Healthineers AG's current Research & Development is MXN41,639 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Siemens Healthineers AG (MEX:SHL N) has a current Research & Development of MXN41,639 Mil. The stock's GF Value™ is MXN1,405.64, compared to a current price of MXN918.93 — trading 34.6% below its estimated fair value. The current Research & Development is MXN41,639 Mil. Siemens Healthineers AG's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Siemens Healthineers AG (MEX:SHL N), the current Research & Development is MXN41,639 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Siemens Healthineers AG (MEX:SHL N) Overvalued in 2026?

Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued. The current stock price of MXN918.93 is trading 34.6% below its estimated GF Value™ of MXN1,405.64.

Key valuation signals for MEX:SHL N:

  • Research & Development: MXN41,639 Mil
  • GF Value™: MXN1,405.64 vs. price of MXN918.93 (34.6% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the MEX:SHL N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Siemens Healthineers AG Business Description

Address Siemensstrasse 3, Forchheim, BY, DEU, 91301
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
72GF Score

Get the complete analysis for MEX:SHL N

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN918.93
Price
MXN1,405.64
GF Value